Close

Goldman Sachs (GS) PT Raised to $451 at BMO Capital

Go back to Goldman Sachs (GS) PT Raised to $451 at BMO Capital

DiscGenics Honored by Goldman Sachs for Entrepreneurship

October 18, 2021 8:34 AM EDT

SALT LAKE CITY, Oct. 18, 2021 /PRNewswire/ -- DiscGenics, Inc., a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced that Goldman Sachs (NYSE: GS) recognized DiscGenics Chairman and CEO Flagg Flanagan as one of the 100 Most Intriguing Entrepreneurs of... More